ARCHIVES

Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive?

This article is from The Cancer Letter archive.

Vol. 38 No. 36 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

AVEO’s Tizozanib Fails in Colorectal Cancer

January 10, 2014

Colorectal Cancer Risk Rises In ADT Use In Prostate Cancer

November 26, 2010

FDA News:: ODAC Commends Ciba For Design Of Trials Legal Issues:

January 10, 1997

Cancer Control Program Guidelines Developed For Payment Of Patient Costs

December 21, 1973

Smoker Sues NCI To Compel Guideline For CT Scanning.

January 25, 2008

NCI-Approved Trials Listed

March 30, 2007